Evidence map›Paper›PMID 38088444›Full record

ReviewBioscience reports2024

Potential promising anticancer applications of β-glucans: a review.

Seyed Mostafa Noorbakhsh Varnosfaderani, Farnoosh Ebrahimzadeh, Mahsa Akbari Oryani, Saeed Khalili, Faezeh Almasi, Reza Mosaddeghi Heris, Zahra Payandeh, Chen Li, Mohsen Nabi Afjadi, Armina Alagheband Bahrami

Open access · goldAbstract readReview
In one paragraph

Review in Bioscience reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
20.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 2 countries.

Seyed Mostafa Noorbakhsh VarnosfaderaniDepartment of Radiology, Afzalipour Hospital, Kerman University of Medical Science, Kerman, Iran.
Farnoosh EbrahimzadehDepartment of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahsa Akbari OryaniDepartment of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Saeed KhaliliDepartment of Biology Sciences, Shahid Rajaee Teacher Training University, Tehran, Iran.
Faezeh AlmasiPharmaceutical Biotechnology Lab, Department of Microbial Biotechnology, School of Biology and Center of Excellence in Phylogeny of Living Organisms, College of Science, University of Tehran, Tehran, Iran.
Reza Mosaddeghi HerisNeurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Zahra PayandehImmunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Chen LiDepartment of Biology, Chemistry, Pharmacy, Free University of Berlin, Berlin, Germany.ORCID 0000-0002-6895-2759
Mohsen Nabi AfjadiDepartment of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Armina Alagheband BahramiDepartment of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran.
Mashhad University of Medical Sciences · IRTabriz University of Medical Sciences · IRFreie Universität Berlin · DEKerman University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRShahid Rajaee Teacher Training University · IRTarbiat Modares University · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Glucans are valuable functional polysaccharides distributed in nature, especially in the cell walls of fungi, yeasts, bacteria, and cereals. The unique features of β-glucans, such as water solubility, viscosity, molecular weight, and so on, have rendered them to be broadly applied in various food systems as well as in medicine to improve human health. Moreover, inhibition of cancer development could be achieved by an increase in immune system activity via β-glucans. β-glucans, which are part of a class of naturally occurring substances known as biological response modifiers (BRMs), have also shown evidence of being anti-tumorogenic, anti-cytotoxic, and anti-mutagenic. These properties make them attractive candidates for use as pharmaceutical health promoters. Along these lines, they could activate particular proteins or receptors, like lactosylceramide (LacCer), Dickin-1, complement receptor 3 (CR3), scavenge receptors (SR), and the toll-like receptor (TLR). This would cause the release of cytokines, which would then activate other antitumor immune cells, like macrophages stimulating neutrophils and monocytes. These cells are biased toward pro-inflammatory cytokine synthesis and phagocytosis enhancing the elicited immunological responses. So, to consider the importance of β-glucans, the present review introduces the structure characteristics, biological activity, and antitumor functions of fungal β-glucans, as well as their application.

Indexed as

beta-GlucansCytokinesHumansMacrophagesNeutrophilsPhagocytosisbeta-GlucansCytokinesantitumorbioactive polysaccharidescancerβ-glucans

Identifiers

PMID38088444
PMCPMC10776902
OpenAlexW4389674999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.